Industry
why Aurinia Pharmaceuticals Inc [AUPH] is a Good Choice for Investors After New Price Target of $10.50
Aurinia Pharmaceuticals Inc [NASDAQ: AUPH] closed the trading session at $5.74. The company report on February 15, 2024 at 6:00 AM that Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value. Total net revenue was $45.1 million and
